L3VLUP
ProSign in

CRSP in the 13F filings

Crispr Therapeutics AG · CUSIP H17182108

Sector · Pharmaceuticals and biotechnologyTheme · Biological productsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
31 Mar 2026
the date the book describes
Filed
18 May 2026
latest of these filings; the earliest 12 May 2026
Managers listing it
20
at least, of 95 tracked, among listed positions
Comparable managers
91
filed both Q4 2025 and Q1 2026; 1 listed it in both
Shares listed
21,756,352
combined, among listed positions
Reported value
$1.0bn
combined, at the quarter end

AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.

Among the 91 comparable managers: 16 buyers (opened or added shares) and 5 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +6,659,399.

Managers listing CRSP in Q1 2026

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q4 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

20 of 20 holders

ActionFiling
ARK Investment Management LLC11,313,623$538m4.19%Added+791,56612 May 2026 (the filing on sec.gov)
Capital World Investors4,725,037$225munder 0.1%Newnew13 May 2026 (the filing on sec.gov)
Fidelity (FMR LLC)1,954,694$93munder 0.1%Added+73715 May 2026 (the filing on sec.gov)
Two Sigma Investments LP1,483,051$71m0.06%Added+1,012,43015 May 2026 (the filing on sec.gov)
Susquehanna International Group LLP593,406$28munder 0.1%Trimmed-260,56515 May 2026 (the filing on sec.gov)
Citadel Advisors LLC516,352$25munder 0.1%Added+248,66715 May 2026 (the filing on sec.gov)
Millennium Management LLC377,178$18munder 0.1%Added+346,68615 May 2026 (the filing on sec.gov)
Squarepoint Ops LLC153,575$7.3munder 0.1%Trimmed-427,53315 May 2026 (the filing on sec.gov)
ExodusPoint Capital Management LP135,129$6.4m0.05%Newnew14 May 2026 (the filing on sec.gov)
AllianceBernstein LP96,357$5.1munder 0.1%Held015 May 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc105,000$5.0munder 0.1%Added+20,06015 May 2026 (the filing on sec.gov)
Man Group PLC90,061$4.3munder 0.1%Added+81,47215 May 2026 (the filing on sec.gov)
Invesco Ltd64,117$3.0munder 0.1%Added+3,32112 May 2026 (the filing on sec.gov)
Tudor Investment Corp43,411$2.1munder 0.1%Added+3,94315 May 2026 (the filing on sec.gov)
Janus Henderson Group Ltd40,274$1.9munder 0.1%Added+5,50018 May 2026 (the filing on sec.gov)
Wellington Management Group LLP34,869$1.7munder 0.1%Added+79715 May 2026 (the filing on sec.gov)
AQR Capital Management LLC22,268$1.1munder 0.1%Added+1,52215 May 2026 (the filing on sec.gov)
Brevan Howard Capital Management LP5,636$268kunder 0.1%Newnew15 May 2026 (the filing on sec.gov)
Quantbot Technologies LP1,399$67kunder 0.1%Trimmed-78513 May 2026 (the filing on sec.gov)
Walleye Capital LLC915$44kunder 0.1%Newnew13 May 2026 (the filing on sec.gov)

Largest increases and reductions, by shares

Q4 2025 to Q1 2026, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (4)

Exited (2)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
4 in Q3 2024 to 3 in Q2 2026

Tracked managers listing it, at least.

035810201820192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
CRSP by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20171$206kn.a.n.a.
Q3 20171$457kn.a.n.a.
Q4 20172$21mn.a.n.a.
Q1 20183$39mn.a.n.a.
Q2 20183$100mn.a.n.a.
Q3 20184$146mn.a.n.a.
Q4 20185$103mn.a.n.a.
Q1 20192$98mn.a.n.a.
Q2 20192$152mn.a.n.a.
Q3 20193$138mn.a.n.a.
Q4 20196$252mn.a.n.a.
Q1 20207$237mn.a.n.a.
Q2 20205$517mn.a.n.a.
Q3 20204$763mn.a.n.a.
Q4 20209$2.0bnn.a.n.a.
Q1 20214$1.3bnn.a.n.a.
Q2 20214$1.5bnn.a.n.a.
Q3 20214$903mn.a.n.a.
Q4 20214$781mn.a.n.a.
Q1 20226$696mn.a.n.a.
Q2 20226$799mn.a.n.a.
Q3 20225$603mn.a.n.a.
Q4 20226$369mn.a.n.a.
Q1 20234$380mn.a.n.a.
Q2 20236$483mn.a.n.a.
Q3 20234$354mn.a.n.a.
Q4 20234$609m23
Q1 20244$595m22
Q2 20245$480m32
Q3 20244$403m15
Q4 20242$388m21
Q1 20253$414m30
Q2 20254$643m40
Q3 20254$748m04
Q4 20251$552m119
Q1 20264$840m165
Q2 20263$883m158

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

CRSP and GILD →CRSP and AMGN →CRSP and ARGX →Choose a stock to compare with CRSP →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own CRSP, latest filings →Back to the 13F Explorer →